Oral Immunization with Lactobacillus casei Expressing the Porcine Circovirus Type 2 Cap and LTB Induces Mucosal and Systemic Antibody Responses in Mice.
Oral Immunization with Lactobacillus casei Expressing the Porcine Circovirus Type 2 Cap and LTB Induces Mucosal and Systemic Antibody Responses in Mice.
复制标题
表达猪圆环病毒 2 型帽和 LTB 的干酪乳杆菌口服免疫可诱导小鼠粘膜和全身抗体反应
DOI:
10.3390/v13071302
复制
发表时间:
2021-07-05
期刊:
影响因子:
--
通讯作者:
Li Y
中科院分区:
文献类型:
--
作者:
Li F;Wang X;Ma R;Wu W;Teng F;Cheng X;Jiang Y;Zhou H;Wang L;Tang L;Qiao X;Li Y
Porcine circovirus type 2 (PCV2) causes many diseases in weaned piglets, leading to serious economic losses to the pig industry. This study investigated the immune response following oral administration of Lactobacillus casei ATCC393 (L. casei 393) expressing PCV2 capsid protein (Cap) fusion with the Escherichia coli heat-labile toxin B subunit (LTB) in mice. Recombinant L. casei strains were constructed using plasmids pPG611.1 and pPG612.1. The expression and localization of proteins from recombinant pPG611.1-Cap-LTB (pPG-1-Cap-LTB)/L. casei 393 and pPG612.1-Cap-LTB (pPG-2-Cap-LTB)/L. casei 393 were detected. All recombinant strains were found to be immunogenic by oral administration in mice and developed mucosal and systemic immune responses against PCV2. The titers of specific antibodies in mice administered pPG-2-Cap-LTB/L. casei 393 were higher than those in mice administered pPG-1-Cap-LTB/L. casei 393 in serum and the mucosal samples. The mucosal immune response was not only limited to the gastrointestinal tract but was also generated in other mucosal parts. Thus, the application of recombinant L. casei could aid in vaccine development for PCV2.
登录
查看更多内容
影响因子:
4.4
作者:
Lee, YK;Ho, PS;Salminen, S
通讯作者:
Salminen, S
影响因子:
2.1
作者:
Oliveira, MLS;Monedero, V;Pérez-Martínez, G
通讯作者:
Pérez-Martínez, G
影响因子:
3.3
作者:
Harding, JCS
通讯作者:
Harding, JCS
影响因子:
3.1
作者:
Mannam, P;Jones, KF;Geller, BL
通讯作者:
Geller, BL
影响因子:
3.1
作者:
Oñate, AA;Céspedes, S;Andrews, E
通讯作者:
Andrews, E